
Package | Dosage | Price | Price per Dose | |
---|---|---|---|---|
Dosage: 90/400mg | ||||
56 pill | 90/400mg | NZD5,641.89 | NZD100.75 | |
28 pill | 90/400mg | NZD3,385.46 | NZD120.91 |

Harvoni Description
Overview of Harvoni
Harvoni is a prescribed medication for the treatment of hepatitis C virus (HCV) infection. It is a combination of two active ingredients, ledipasvir and sofosbuvir, designed to work together to eliminate the virus from the body. This medication has revolutionised hepatitis C treatment, offering a simpler, more effective option compared to older therapies that involved injections and longer treatment durations.
How Harvoni Works
Harvoni functions by targeting specific proteins essential for the replication of the hepatitis C virus. Sofosbuvir acts as a nucleotide analogue that inhibits the virus's RNA polymerase, preventing viral RNA replication. Ledipasvir interferes with the NS5A protein, which is crucial for viral replication and assembly. When used together, these drugs have been shown to achieve high cure rates, often exceeding 95%, among various genotypes of hepatitis C.
Benefits of Using Harvoni in New Zealand
In New Zealand, many patients with hepatitis C now have access to Harvoni through the public health system or private healthcare providers. The medication is well tolerated with fewer side effects, making it a preferable choice for many. Its relatively short course, typically 8 to 12 weeks, means patients can achieve a cure without the extensive treatment durations associated with older therapies.
Moreover, Harvoni can be safely used by patients with liver cirrhosis, including those awaiting liver transplants, which is a common concern among individuals with chronic hepatitis C. The high success rate with Harvoni offers hope for many who seek to eliminate the virus and improve their liver health.
Possible Side Effects and Considerations
While Harvoni is generally safe, some users may experience side effects. Common issues include headache, fatigue, nausea, and trouble sleeping. Serious side effects are rare but may include allergic reactions or interactions with other medications. It is crucial to inform your healthcare provider about any other medicines you are taking, especially if you are on medications for heart problems or other chronic conditions.
Pet owners in New Zealand should also be aware that while Harvoni is suitable for human use only, keeping all medications out of reach of pets is essential to avoid accidental ingestion.
Availability and Purchase in New Zealand
In New Zealand, Harvoni can be obtained via a doctor’s prescription. It is available through licensed pharmacies, both in-store and online. Always ensure that you source your medication from reputable providers to guarantee quality and authenticity. Consulting your healthcare provider before purchasing is vital to confirm you are eligible and to establish the correct treatment plan.
Pricing may vary, but many patients find that private options are more accessible, especially if they do not qualify for public funding. Some online pharmacies offer convenient ordering options, but caution should be exercised to avoid counterfeit products. Verify the credentials of the pharmacy before making any purchase.
Patient Experiences and Success Rates
Many New Zealand patients report positive experiences with Harvoni. Cure rates are very high, and the straightforward daily regimen improves compliance compared to earlier treatments. People often appreciate the quick turnaround in their health status and the chance to resume their normal lives without the burden of ongoing illness or side effects caused by older medications.
It is important for patients to follow their healthcare provider’s instructions strictly to ensure the best outcomes. Regular monitoring through blood tests is usually recommended to track the virus’s presence during and after treatment. Overall, Harvoni offers a promising option for those seeking an effective solution to hepatitis C in New Zealand.